| Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasia. | |
| | |
MedLine Citation:
|
PMID: 23024707 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) commonly affect older men. These bothersome symptoms can lead to a decreased quality of life. Currently, two classes of drugs - α-adrenergic blockers and 5α-reductase inhibitors - are prescribed to treat LUTS secondary to BPH. Due to their different mechanisms of action, these medications work in a synergistic manner. Trials of combination therapy have been conducted to assess its effect compared with monotherapy. Current data support combination therapy in men with moderately enlarged prostates and moderate to severe symptoms. |
| | |
Authors:
|
Bilal Chughtai; Dean S Elterman; Richard Lee; Alexis E Te; Steven A Kaplan |
Related Documents
:
|
22955007 - Adherence to treatment guidelines in clinical practice: study of antipsychotic treatmen... 22148897 - Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis... 23438287 - Role of statins in alzheimer's disease: a retrospective meta-analysis for commonly inve... 23514317 - The epidemiology of depression across cultures. 22548767 - Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gast... 22747667 - Mirroring everyday clinical practice in clinical trial design: a new concept to improve... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Therapeutic advances in urology Volume: 4 ISSN: 1756-2880 ISO Abbreviation: Ther Adv Urol Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-01 Completed Date: 2012-10-02 Revised Date: 2013-04-02 |
Medline Journal Info:
|
Nlm Unique ID: 101487328 Medline TA: Ther Adv Urol Country: England |
Other Details:
|
Languages: eng Pagination: 267-72 Citation Subset: - |
Affiliation:
|
James Buchanan Brady Department of Urology, Weill Cornell Medical College of Cornell University, New York, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Experience with sunitinib in the treatment of metastatic renal cell carcinoma.
Next Document: Sirtuin biology and relevance to diabetes treatment.